Next Quarterly Earnings
Tuesday, November 3, 2026
CW 45
After-Hours
In 68 days
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Amgen
Amgen is a leading, US-based biotechnology company. It focuses on the research, development, and delivery of innovative biopharmaceuticals to help patients with serious illnesses worldwide. Through scientific excellence, Amgen creates life-changing therapies and improves healthcare.
Recap: the latest results
Amgen (AMGN) reported its Q2 2026 financial results on August 4, 2026, after market close. The company announced an EPS of 6.29 USD, beating the analyst estimate of 5.61 USD by 12.2%. Revenue reached 10054 million USD for the quarter, and the stock price reacted with an increase of 4.57% after the release.
Generated automatically from our data — as of 08/12/2026 Read the article →
Frequently asked questions
When will Amgen report its next quarterly earnings?
Amgen is scheduled to report its next quarterly earnings on 11/03/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
When did Amgen last report quarterly earnings?
Amgen last reported quarterly earnings on 8/4/2026 (Q2 2026). Earnings per share (EPS) came in at 6.29 USD.
How does Amgen stock react to earnings?
Across its last 5 earnings reports, Amgen stock moved by ±6.4% on average the following day. The largest reaction was +8.2% on 02/03/2026; 4 of 5 reactions were positive.
How often has Amgen beaten expectations?
Amgen has beaten analyst EPS estimates in 5 of its last 5 evaluated quarters (beat rate: 100%).
How do I add the Amgen earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
All Dates
Earnings statistics
Stock reaction to earnings
±6.4%
Avg. next-day move
+8.2%
Largest move (02/03/2026)
80%
Share of positive reactions
±7.1%
Avg. move after 7 days
Basis: price reactions to the last 5 report dates (close to close).
Estimates vs. results
5/5
Quarters above estimates
100%
Beat rate
+6.4%
Avg. EPS surprise
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.
Company Information
Name
Amgen
Country
🇺🇸
Index membership
More Financial Information